[Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000404:Ajmaline / Q000008:administration & dosage; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D001949:Bretylium Compounds / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007267:Injections; D008012:Lidocaine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D011342:Procainamide / Q000008:administration & dosage; D011802:Quinidine / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D000404:Ajmaline; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide
Medikamentöse Arrhythmieprophylaxe und -therapie beim akuten Myokardinfarkt.